Expand Document  |  Expand Chapter  |  Full TOC  |  Printable HTML version
General Guidelines for Methodologies on Research and Evaluation of Traditional Medicine
(2000; 80 pages) [French] [Spanish] View the PDF document
Table of Contents
View the documentAcknowledgements
View the documentForeword
Open this folder and view contentsIntroduction
Open this folder and view contents1. Methodologies for Research and Evaluation of Herbal Medicines
Open this folder and view contents2. Methodologies for Research and Evaluation of Traditional Procedure-Based Therapies
Open this folder and view contents3. Clinical Research
Open this folder and view contents4. Other Issues and Considerations
View the documentReferences
Open this folder and view contentsAnnexes
Open this folder and view contentsAnnex I. Guidelines for the Assessment of Herbal Medicinesa
Open this folder and view contentsAnnex II. Research Guidelines for Evaluating the Safety and Efficacy of Herbal Medicinesa
Open this folder and view contentsAnnex III. Report of a WHO Consultation on Traditional Medicine and AIDS: Clinical Evaluation of Traditional Medicines and Natural Productsa
Open this folder and view contentsAnnex IV. Definition of Levels of Evidence and Grading of Recommendationa
Open this folder and view contentsAnnex V. Guidelines for Levels and Kinds of Evidence to Support Claims for Therapeutic Goodsa
Open this folder and view contentsAnnex VI. Guidelines for Good Clinical Practice (GCP) for Trials on Pharmaceutical Productsa
Open this folder and view contentsAnnex VII. Guidance for Industry: Significant Scientific Agreement in the Review of Health Claims for Conventional Foods and Dietary Supplementsa
Open this folder and view contentsAnnex VIII. Guideline for Good Clinical Practicea
Open this folder and view contentsAnnex IX. WHO QOL (Quality of Life) User Manual: Facet Definitions and Response Scalesa
View the documentAnnex X. Participants in the WHO Consultation on Methodologies for Research and Evaluation of Traditional Medicine
 

Annex X. Participants in the WHO Consultation on Methodologies for Research and Evaluation of Traditional Medicine

Hong Kong Special Administrative Region of China (Hong Kong SAR), 11-14 April 2000

Dr Linda Anderson, Department of Health, Medicines Control Agency, London, UK

Dr David Briggs, Office of Complementary Medicines, Therapeutic Goods Administration, Commonwealth Department of Health and Family Services, Woden, Australia

Dr Francesco Cardini, Verona, Italy

Dr Margaret F.C. Chan, Department of Health, Hong Kong SAR

Dr Peter Chan, Office of Natural Health Products, Health Canada, Ottawa, Canada

Ms Smt Shailaja Chandra, Department of Indian Systems of Medicine and Homoeopathy, Ministry of Health and Family Welfare, New Delhi, India

Professor Il-Moo Chang, WHO Collaborating Centre for Traditional Medicine, Natural Products Research Institute, Seoul National University, Seoul, Republic of Korea

Professor Ranjit Roy Chaudhury, National Institute of Immunology, New Delhi, India

Dr A. Majid Cheraghali, National Quality Control Lab for Food and Drugs, Ministry of Health and Medical Education, Tehran, Islamic Republic of Iran

Professor Harry H.S. Fong, WHO Collaborating Centre for Traditional Medicine, College of Pharmacy, The University of Illinois at Chicago, Chicago, IL, USA

Professor Fung Kwok-pui, Department of Biochemistry, The Chinese University of Hong Kong, Hong Kong SAR

Professor Emil Gabrielyan, Drug and Medical Technology Agency (MHRA), Ministry of Health, Yerevan, Armenia

Dr Benjamin Gilbert, Institute of Pharmaceutical Technology, Rio de Janeiro, Brazil

Dr Lynton G.F. Giles, Townsville General Hospital, Townsville, Australia

Dr Motasim Habibullah, Zayed Complex for Herbal Research and Traditional Medicine, Ministry of Health, Abu Dhabi, United Arab Emirates

Dr Konstantin Keller, Federal Institute for Drugs and Medical Devices, Federal Health Office, Bonn, Germany

Dr Eftychios Kkolos, Pharmaceutical Services, Ministry of Health, Nicosia, Cyprus

Mr Kwan Sik-yiu, Hong Kong Government Laboratory, Hong Kong SAR

Professor Lai Shilong, National Centre for Training of Design, Measurement, Evaluation in Clinical Research, Guangzhou University of Traditional Chinese Medicine, Guangzhou, China

Dr Ping Yan Lam, Department of Health, Hong Kong SAR

Professor Lam Tai Hing, Department of Community Medicine and Unit for Behavioural Sciences, The University of Hong Kong, Hong Kong SAR

Professor Lin Rui Chao, Division of Chinese Materia Medica and Natural Products, National Institute for the Control of Pharmaceutical and Biological Products, State Drug Administration, Beijing, China

Mr Isaac B. Mayeng, Medicine Administration, Complementary Medicines, Medicines Control Council, Department of Health, Pretoria, South Africa

Dr Richard Nahin, WHO Collaborating Centre for Traditional Medicine, The National Center for Complementary and Alternative Medicine, National Institutes of Health, Bethesda, MD, USA

Professor G. E. Osuide, National Agency for Food and Drug Administration and Control, Abuja, Nigeria

Professor Tamás Paál, National Institute of Pharmacy, Budapest, Hungary

Dr Ketut Ritiasa, Traditional Drug Control, Directorate General of Drug and Food Control, Ministry of Health, Jakarta, Indonesia

Dr Motoyoshi Satake, Division of Pharmacognosy and Phytochemistry, National Institute of Health Sciences, Ministry of Health and Welfare, Tokyo, Japan

Dr Antoine Sawaya, Pharmaceutical Quality Department, French Agency of Health Products, Saint Denis, France

Professor Umberto Solimene, WHO Collaborating Centre for Traditional Medicine, Centre of Research in Bioclimatology, Biotechnologies and Natural Medicine, State University of Milan, Milan, Italy

Dr Pennapa Subcharoen, National Institute of Thai Traditional Medicine, Department of Medical Services, Ministry of Public Health, Nonthaburi, Thailand

Professor Zhu-fan Xie, Institute for Integration of Traditional Chinese and Western Medicine, First Hospital, Beijing Medical University, Beijing, China

Professor Yang Weiyi, School of Traditional Chinese Medicine, Faculty of Science, Hong Kong Baptist University, Hong Kong SAR

WHO Temporary Advisers:

Dr Torkel Falkenberg, Department of Public Health Sciences, Division of International Health, Karolinska Institute, Stockholm, Sweden

Dr Ting Hung Leung, Department of Health, Hong Kong SAR

WHO Secretariat:

Dr Guo Jun Cai, Coordinator, Ageing and Health Programme, WHO Centre for Health Development, Kobe, Japan

Dr Chen Ken, Regional Adviser, Traditional Medicine, World Health Organization Regional Office for the Western Pacific, Manila, Philippines

Mr Peter Graaff, Regional Adviser, Essential Drugs and Biologicals, World Health Organization Regional Office for the Eastern Mediterranean, Cairo, Egypt

Dr Ossy Kasilo, Regional Adviser, Traditional Medicine, World Health Organization Regional Office for Africa, Harare, Zimbabwe

Dr Kin Shein, Regional Adviser, Essential Drugs and Medicines Policy, World Health Organization Regional Office for South-East Asia, New Delhi, India

Dr Xiaorui Zhang, Acting Coordinator, Traditional Medicine, Department of Essential Drugs and Medicines Policy, World Health Organization, Geneva, Switzerland

to previous section
 
 
The WHO Essential Medicines and Health Products Information Portal was designed and is maintained by Human Info NGO. Last updated: August 29, 2014